Cargando…
Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay
A monoclonal antibody (mAb) against zearalenone (ZEN) was produced using ZEN-carboxymethoxylamine and -BSA conjugates. Antibody produced by one clone showing a very high binding ability was selected and found to have a higher affinity for ZEN compared to a commerciall ZEN antibody. We developed two...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Veterinary Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386336/ https://www.ncbi.nlm.nih.gov/pubmed/22705733 http://dx.doi.org/10.4142/jvs.2012.13.2.119 |
_version_ | 1782236968411725824 |
---|---|
author | Cha, Sang-Ho Kim, Sung-Hee Bischoff, Karyn Kim, Hyun-Jeong Son, Seong-Wan Kang, Hwan-Goo |
author_facet | Cha, Sang-Ho Kim, Sung-Hee Bischoff, Karyn Kim, Hyun-Jeong Son, Seong-Wan Kang, Hwan-Goo |
author_sort | Cha, Sang-Ho |
collection | PubMed |
description | A monoclonal antibody (mAb) against zearalenone (ZEN) was produced using ZEN-carboxymethoxylamine and -BSA conjugates. Antibody produced by one clone showing a very high binding ability was selected and found to have a higher affinity for ZEN compared to a commerciall ZEN antibody. We developed two direct competitive ELISA systems using the selected antibody (ZEN-coated and anti-ZEN antibody-coated ELISA). Quantitative ranges for the anti-ZEN antibody-coated ELISA and ZEN-coated ELISA were from 25 to 750 ppb and from 12.5 to 100 ppb, respectively. The detection limit of both methods as measured with standard solutions was 10 ppb. The intra-plate and inter-well variation of both ELISAs were less than 10%. The IC(50) values for α-zearalenol, β-zearalenol, α-zearalanol, and β-zearalanol compared to ZEN were 108.1, 119.3, 114.1, and 130.3% for the ZEN-coated ELISA. These values were 100.7, 120.7, 121.6, and 151.6% for the anti-ZEN antibody-coated ELISA. According to the anti-ZEN antibody-coated ELISA, the average recovery rates of ZEN from spiked animal feed containing 150 to 600 ng/mL of ZEN ranged from 106.07 to 123.00% with 0.93 to 2.28% coefficients of variation. Our results demonstrate that the mAb developed in this study could be used to simultaneously screen for ZEN and its metabolites in feed. |
format | Online Article Text |
id | pubmed-3386336 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | The Korean Society of Veterinary Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-33863362012-07-09 Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay Cha, Sang-Ho Kim, Sung-Hee Bischoff, Karyn Kim, Hyun-Jeong Son, Seong-Wan Kang, Hwan-Goo J Vet Sci Original Article A monoclonal antibody (mAb) against zearalenone (ZEN) was produced using ZEN-carboxymethoxylamine and -BSA conjugates. Antibody produced by one clone showing a very high binding ability was selected and found to have a higher affinity for ZEN compared to a commerciall ZEN antibody. We developed two direct competitive ELISA systems using the selected antibody (ZEN-coated and anti-ZEN antibody-coated ELISA). Quantitative ranges for the anti-ZEN antibody-coated ELISA and ZEN-coated ELISA were from 25 to 750 ppb and from 12.5 to 100 ppb, respectively. The detection limit of both methods as measured with standard solutions was 10 ppb. The intra-plate and inter-well variation of both ELISAs were less than 10%. The IC(50) values for α-zearalenol, β-zearalenol, α-zearalanol, and β-zearalanol compared to ZEN were 108.1, 119.3, 114.1, and 130.3% for the ZEN-coated ELISA. These values were 100.7, 120.7, 121.6, and 151.6% for the anti-ZEN antibody-coated ELISA. According to the anti-ZEN antibody-coated ELISA, the average recovery rates of ZEN from spiked animal feed containing 150 to 600 ng/mL of ZEN ranged from 106.07 to 123.00% with 0.93 to 2.28% coefficients of variation. Our results demonstrate that the mAb developed in this study could be used to simultaneously screen for ZEN and its metabolites in feed. The Korean Society of Veterinary Science 2012-06 2012-06-15 /pmc/articles/PMC3386336/ /pubmed/22705733 http://dx.doi.org/10.4142/jvs.2012.13.2.119 Text en © 2012 The Korean Society of Veterinary Science. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Cha, Sang-Ho Kim, Sung-Hee Bischoff, Karyn Kim, Hyun-Jeong Son, Seong-Wan Kang, Hwan-Goo Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay |
title | Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay |
title_full | Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay |
title_fullStr | Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay |
title_full_unstemmed | Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay |
title_short | Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay |
title_sort | production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386336/ https://www.ncbi.nlm.nih.gov/pubmed/22705733 http://dx.doi.org/10.4142/jvs.2012.13.2.119 |
work_keys_str_mv | AT chasangho productionofahighlygroupspecificmonoclonalantibodyagainstzearalenoneanditsapplicationinanenzymelinkedimmunosorbentassay AT kimsunghee productionofahighlygroupspecificmonoclonalantibodyagainstzearalenoneanditsapplicationinanenzymelinkedimmunosorbentassay AT bischoffkaryn productionofahighlygroupspecificmonoclonalantibodyagainstzearalenoneanditsapplicationinanenzymelinkedimmunosorbentassay AT kimhyunjeong productionofahighlygroupspecificmonoclonalantibodyagainstzearalenoneanditsapplicationinanenzymelinkedimmunosorbentassay AT sonseongwan productionofahighlygroupspecificmonoclonalantibodyagainstzearalenoneanditsapplicationinanenzymelinkedimmunosorbentassay AT kanghwangoo productionofahighlygroupspecificmonoclonalantibodyagainstzearalenoneanditsapplicationinanenzymelinkedimmunosorbentassay |